Economic Issues in Heart Failure in the United States.
J Card Fail
; 28(3): 453-466, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-35085762
ABSTRACT
The cost of heart failure care is high owing to the cost of hospitalization and chronic treatments. Heart failure treatments vary in their benefit and cost. The cost effectiveness of therapies can be determined by comparing the cost of treatment required to obtain a certain benefit, often defined as an increase in 1 year of life. This review was sponsored by the Heart Failure Society of America and describes the growing economic burden of heart failure for patients and the health care system in the United States. It also provides a summary of the cost effectiveness of drugs, devices, diagnostic tests, hospital care, and transitions of care for patients with heart failure. Many medications that are no longer under patent are inexpensive and highly cost-effective. These include angiotensin-converting enzyme inhibitors, beta-blockers and mineralocorticoid receptor antagonists. In contrast, more recently developed medications and devices, vary in cost effectiveness, and often have high out-of-pocket costs for patients.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Heart Failure
Type of study:
Diagnostic_studies
/
Health_economic_evaluation
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
J Card Fail
Journal subject:
CARDIOLOGIA
Year:
2022
Type:
Article